istock-504614550_brauns-1

brauns / iStockphoto.com

29 June 2017GeneticsMarisa Moura Momoli

CRISPR in Brazil: dealing with breakthrough technology

In 2012, the world was introduced to one of the greatest scientific discoveries in recent years: CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

CRISPR patents revoked following Nobel Prize winners’ withdrawal

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

How to navigate patent term adjustment in China

‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards

Preventative IP for preventative pharma healthcare

Dexcom suffers second patent revocation at hands of UPC